AI assistant
Sending…
EyePoint Pharmaceuticals, Inc. — Director's Dealing 2016
Aug 3, 2016
32254_dirs_2016-08-03_e814c5c7-fccc-4f09-8380-55a672d4c534.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2016-08-01
Reporting Person: Paggiarino Dario A. (Chief Medical Officer)
More from EyePoint Pharmaceuticals, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 6
Investor Presentation
2026
Apr 13
Director's Dealing
2026
Mar 24
Legal Proceedings Report
2026
Mar 20
Regulatory Filings
2026
Mar 4
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Jan 7